NCT03095521 - A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol] and ANTI-ANGIN® FORMULA, Lozenges, in Treatment of Patients With a Sore Throat | Biotech Hunter

Enrollment

228

Participants

Timeline

Start Date

February 22, 2017

Primary Completion Date

May 7, 2017

Study Completion Date

May 7, 2017

Conditions

Sore Throat

Interventions

DRUG

Angal, lozenges [menthol],

Angal, administered per 1 lozenge, with an interval 2 hours or more, 6-10 lozenges per day, for a maximum 4 days or until full illness resolution.

DRUG

ANTI-ANGIN® FORMULA

"0,2 mg + 2 mg + 50 mg (LLC Valeant, Russia). Administered per 1 lozenge, with an interval 2 hours or more, up to 6 lozenges per day, for a maximum 5 days or until full illness resolution."

Trial Locations (14)

105018

Sandoz Investigational Site, Moscow

115280

Sandoz Investigational Site, Moscow

119192

Sandoz Investigational Site, Moscow

127015

Sandoz Investigational Site, Moscow

135215

Sandoz Investigational Site, Moscow